A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Wake Forest University Health Sciences
Roswell Park Cancer Institute
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Baylor College of Medicine
Thomas Jefferson University
University of Chicago
Takeda
University of Colorado, Denver
Hutchmed
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Masonic Cancer Center, University of Minnesota
Acerta Pharma BV
H. Lee Moffitt Cancer Center and Research Institute
City of Hope Medical Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
University of Washington
City of Hope Medical Center
Takeda
Thomas Jefferson University
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Seagen Inc.
City of Hope Medical Center
Affimed GmbH
Emory University
University of Washington
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Thomas Jefferson University
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
AIDS Malignancy Consortium
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
Shattuck Labs, Inc.
City of Hope Medical Center
City of Hope Medical Center